Compare CNMD & BCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNMD | BCX |
|---|---|---|
| Founded | 1970 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 985.5M | 898.8M |
| IPO Year | 1995 | N/A |
| Metric | CNMD | BCX |
|---|---|---|
| Price | $49.19 | $13.25 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $46.25 | N/A |
| AVG Volume (30 Days) | ★ 306.8K | 148.1K |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | 1.11% | ★ 6.99% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.22 | N/A |
| Revenue | ★ $1,374,724,000.00 | N/A |
| Revenue This Year | $0.82 | N/A |
| Revenue Next Year | $5.48 | N/A |
| P/E Ratio | $40.26 | ★ N/A |
| Revenue Growth | ★ 5.18 | N/A |
| 52 Week Low | $31.44 | $9.68 |
| 52 Week High | $56.64 | $13.86 |
| Indicator | CNMD | BCX |
|---|---|---|
| Relative Strength Index (RSI) | 54.68 | 71.32 |
| Support Level | $48.41 | $11.90 |
| Resistance Level | $53.09 | $13.37 |
| Average True Range (ATR) | 1.43 | 0.21 |
| MACD | -0.55 | 0.02 |
| Stochastic Oscillator | 8.81 | 97.72 |
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
BlackRock Resources & Commodities Strategy Trust operates as an investment trust. Its investment objective is to seek high current income and current gains, with a secondary objective of capital appreciation. The company invests at least 80% of its total assets in equity securities issued by commodity or natural resources companies, derivatives with exposure to commodity or natural resources companies, or investments in securities and derivatives linked to the underlying price movement of commodities or natural resources.